Cargando…

Biological variation and reference change values of serum Mac‐2–binding protein glycosylation isomer (M2BPGi)

BACKGROUND: Limited data are available with regard to biological variations of the Mac‐2–binding protein glycosylation isomer (M2BPGi), a liver fibrosis biomarker. METHODS: Long‐term biological variation of M2BPGi was investigated using longitudinally measured M2BPGi test results from healthy Korean...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Rihwa, Chun, Gayoung, Go, Unyeong, Lee, Sang Gon, Lee, Eun Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993623/ https://www.ncbi.nlm.nih.gov/pubmed/35285104 http://dx.doi.org/10.1002/jcla.24319

Ejemplares similares

Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis
por: Migita, Kiyoshi, et al.
Publicado: (2018)

Diagnostic performance of Mac‐2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups
por: Nah, Eun‐Hee, et al.
Publicado: (2020)

Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa
por: Vincent, Jeanne Perpétue, et al.
Publicado: (2022)

Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis
por: Migita, Kiyoshi, et al.
Publicado: (2020)

On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy
por: Murata, Ayato, et al.
Publicado: (2020)

The Serum Mac-2-binding Protein Glycosylation Isomer Dynamics in Acute Liver Injury
por: Seike, Takuya, et al.
Publicado: (2020)

Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases
por: Tamaki, Nobuharu, et al.
Publicado: (2021)

Serum Mac-2 Binding Protein Glycosylation Isomer Concentrations Are Associated With Incidence of Type 2 Diabetes
por: Higashioka, Mayu, et al.
Publicado: (2023)

Mac-2 Binding Protein Glycosylation Isomer: Emerging Non-Invasive Serum Marker for Liver Fibrosis
por: Cho, Sun Young, et al.
Publicado: (2018)

Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease
por: Tangvoraphonkchai, Kawin, et al.
Publicado: (2022)

Mac-2-binding protein glycosylation isomer is useful to predict muscle cramps in patients with chronic liver disease
por: Miwa, Takao, et al.
Publicado: (2022)

Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients
por: Wu, Pei-Shan, et al.
Publicado: (2021)

Usefulness of serum Mac-2 binding protein glycosylation isomer in patients undergoing hepatectomy: A case controlled study
por: Hiyoshi, Masahide, et al.
Publicado: (2019)

Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma
por: Nakai, Masato, et al.
Publicado: (2022)

Reference intervals of anti‐Müllerian hormone in Korean women
por: Choi, Rihwa, et al.
Publicado: (2022)

Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases
por: Jang, Se Young, et al.
Publicado: (2021)

Mac‐2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection
por: Jun, Tomi, et al.
Publicado: (2019)

Combined albumin-bilirubin grade and Mac-2 binding protein glycosylation isomer as a useful predictor in compensated liver cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2019)

Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis
por: Kiyoaki, Ito, et al.
Publicado: (2022)

Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients
por: Mak, Lung-Yi, et al.
Publicado: (2019)

Measurements of Serum Mac-2-Binding Protein Glycosylation Isomer and Shear Wave Velocity in Health Checkups Are Useful in Screening for Non-Alcoholic Steatohepatitis
por: Tamai, Hideyuki, et al.
Publicado: (2021)

Elevation of Mac‐2 binding protein glycosylation isomer after hepatectomy is associated with post‐hepatectomy liver failure, total Pringle time, and renal dysfunction
por: Imai, Daisuke, et al.
Publicado: (2019)

A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy
por: Chen, Chien-Hung, et al.
Publicado: (2022)

Clinical usefulness of Mac-2 binding protein glycosylation isomer for diagnosing liver cirrhosis and significant fibrosis in patients with chronic liver disease: A retrospective single-center study
por: Park, Hyun Joon, et al.
Publicado: (2022)

Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases
por: Moon, Hee-Won, et al.
Publicado: (2018)

Baseline serum Mac-2 binding protein glycosylation isomer as a predictor of hepatocellular carcinoma in chronic hepatitis B patients: a systematic review and meta-analysis
por: Witarto, Andro Pramana, et al.
Publicado: (2022)

Combination of Mac-2 Binding Protein Glycosylation Isomer and Up-To-Seven Criteria as a Useful Predictor for Child-Pugh Grade Deterioration after Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Eso, Yuji, et al.
Publicado: (2019)

Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer
por: Hur, Mina, et al.
Publicado: (2022)

Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling
por: Dolgormaa, Gantumur, et al.
Publicado: (2020)

Seroprevalence of CMV IgG and IgM in Korean women of childbearing age
por: Choi, Rihwa, et al.
Publicado: (2021)

Clinical implications of serum Mac-2-binding protein glycan isomer as a novel biomarker of advanced hepatic fibrosis in diabetes
por: Park, Huiyul, et al.
Publicado: (2020)

Mac‐2‐binding protein glycan isomer predicts all malignancies after sustained virological response in chronic hepatitis C
por: Kawata, Kazuhito, et al.
Publicado: (2022)

Significant Correlation Between Grip Strength and m2bpgi in Patients with Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2019)

Impact of M2BPGi on the Hepatocarcinogenesis after the Combination Therapy with Daclatasvir and Asunaprevir for Hepatitis C
por: Takakusagi, Satoshi, et al.
Publicado: (2021)

Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B
por: Bui, Hoang Huu, et al.
Publicado: (2023)

Utilization of Glucose-6-Phosphate Dehydrogenase Test and the Prevalence of Enzyme Deficiency in Korea
por: Choi, Rihwa, et al.
Publicado: (2023)

Investigation of the Prevalence of Diminished Ovarian Reserve in Korean Women of Reproductive Age
por: Choi, Rihwa, et al.
Publicado: (2023)

The Utilization of Serum Folate and Homocysteine Tests and the Prevalence of Folate Deficiency in Reproductive-Age Korean Women during the COVID-19 Pandemic
por: Choi, Rihwa, et al.
Publicado: (2023)

Exploring Utilization and Establishing Reference Intervals for the Apolipoprotein B Test in the Korean Population
por: Choi, Rihwa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e6mteio5f0tem14n0vp1phf7tp